Literature DB >> 15867488

Antiretroviral therapies for treatment-experienced patients: current status and research challenges.

Kimberly Struble, Jeffrey Murray, Ben Cheng, Thomas Gegeny, Veronica Miller, Roy Gulick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15867488     DOI： 10.1097/01.aids.0000168968.34810.ca

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  9 in total

1.  Strategies for recognition of stem-loop RNA structures by synthetic ligands: application to the HIV-1 frameshift stimulatory sequence.

Authors:  Prakash B Palde; Leslie O Ofori; Peter C Gareiss; Jaclyn Lerea; Benjamin L Miller
Journal:  J Med Chem       Date:  2010-08-26       Impact factor: 7.446

Review 2.  Novel clinical trial designs for the development of new antiretroviral agents.

Authors:  Nina Mani; Jeffrey Murray; Roy M Gulick; Filip Josephson; Veronica Miller; Peter Miele; Jur Strobos; Kimberly Struble
Journal:  AIDS       Date:  2012-05-15       Impact factor: 4.177

3.  Novel antiretroviral agents in HIV therapy.

Authors:  Caitlin Reed; Eric S Daar
Journal:  Curr Infect Dis Rep       Date:  2006-11       Impact factor: 3.725

4.  AIDS clinical trials group longitudinal linked randomized trials (ALLRT): rationale, design, and baseline characteristics.

Authors:  Marlene Smurzynski; Ann C Collier; Susan L Koletar; Ronald J Bosch; Kunling Wu; Barbara Bastow; Constance A Benson
Journal:  HIV Clin Trials       Date:  2008 Jul-Aug

5.  Prodrug and conjugate drug delivery strategies for improving HIV/AIDS therapy.

Authors:  M S Palombo; Y Singh; P J Sinko
Journal:  J Drug Deliv Sci Technol       Date:  2009       Impact factor: 3.981

6.  Clinical and Economic Impact of Ibalizumab for People With Multidrug-Resistant HIV in the United States.

Authors:  Lucia R I Millham; Justine A Scott; Paul E Sax; Fatma M Shebl; Krishna P Reddy; Elena Losina; Rochelle P Walensky; Kenneth A Freedberg
Journal:  J Acquir Immune Defic Syndr       Date:  2020-02-01       Impact factor: 3.771

7.  Digoxin suppresses HIV-1 replication by altering viral RNA processing.

Authors:  Raymond W Wong; Ahalya Balachandran; Mario A Ostrowski; Alan Cochrane
Journal:  PLoS Pathog       Date:  2013-03-28       Impact factor: 6.823

8.  Characterization of novel inhibitors of HIV-1 replication that function via alteration of viral RNA processing and rev function.

Authors:  Raymond W Wong; Ahalya Balachandran; Matthew Haaland; Peter Stoilov; Alan Cochrane
Journal:  Nucleic Acids Res       Date:  2013-08-13       Impact factor: 16.971

9.  Patient-Reported Outcomes in the Phase III BRIGHTE Trial of the HIV-1 Attachment Inhibitor Prodrug Fostemsavir in Heavily Treatment-Experienced Individuals.

Authors:  Sarah-Jane Anderson; Miranda Murray; David Cella; Robert Grossberg; Debbie Hagins; William Towner; Marcia Wang; Andrew Clark; Amy Pierce; Cyril Llamoso; Peter Ackerman; Max Lataillade
Journal:  Patient       Date:  2021-06-28       Impact factor: 3.883
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.